NCT07862439: Biomarker-guided Reduction of Immunosuppression in Liver Transplant Recipients (BRITRE)
- State
- Not started
- Phase
- Phase 2
- People
- 180 planned
- Started
- Jan 2027
- Primary completion
- Jan 2031
- Arms
- miRNA Biomarker-Guided Immunosuppression Minimization
- Results
- None posted
- 7 Oct 2026: Trial registered